Shinpoong Pharmaceutical to Acquire Hyundai Pharm Shares Worth 29.6 Billion Won, Raising Stake to 7.2%
Shinpoong Pharmaceutical announced on the 26th that it will acquire 2,307,929 shares of Hyundai Pharm, a pharmaceutical manufacturing and sales company, for about 29.6 billion won.
After the share acquisition, Shinpoong Pharmaceutical's stake in Hyundai Pharm will be 7.2%. The scheduled acquisition date is the 27th.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Shinpoong Pharmaceutical stated that the purpose of this share acquisition is "to create business synergies through a strategic alliance and to strengthen the research and development (R&D) partnership."
Shinpoong Pharmaceutical Ansan Piramax dedicated factory. Shinpoong Pharmaceutical
View original image© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.